RUNX2 and metabolic dysfunction-associated steatohepatitis: The upregulation of RUNX2 was verified in the cirrhosis, NAFLD, NASH and HBV‐related fibrosis datasets (Figure 1J; Figure S2G–I, Supporting Information).